Rotavirus genotypes in children with gastroenteritis assisted in two public hospitals from Chile: Viral strains circulating in a country without a universal vaccination against rotavirus;Genotipos de rotavirus aislados de niños chilenos con gastroenteritis atendidos en dos hospitales públicos: Variantes virales circulantes en un país con uso limitado de vacunas anti-rotavirus

Revista Chilena de Infectologia

Volumn 29, Issue 2, 2012, Pages 142-148

  Lucero, Yalda ^a   Mamani, Nora ^a   Cortés, Héctor ^a   Peña, Alfredo ^b   Vergara, Rodrigo ^c   Gallardo, Miguel O'Ryan ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c UNIVERSIDAD DE VALPARAÍSO   (Chile)

Author keywords

Acute gastroenteritis; Epidemiology; Rotavirus; Vaccine; Viral genotypes

Indexed keywords

VIRUS RNA;

ARTICLE; CHILE; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; GASTROENTERITIS; GENETICS; GENOTYPE; HUMAN; INFANT; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PUBLIC HOSPITAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROTAVIRUS; ROTAVIRUS INFECTION; SEASON; VIROLOGY;

CHILD, PRESCHOOL; CHILE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; GASTROENTERITIS; GENOTYPE; HOSPITALS, PUBLIC; HUMANS; INFANT; MALE; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; ROTAVIRUS; ROTAVIRUS INFECTIONS; SEASONS;

EID: 84861939470     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: 10.4067/S0716-10182012000200004     Document Type: Article

References (30)

1. Parashar U, Gibson C, Bresee J, Glass R. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006; 12: 304-6.
2. Parashar U, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009; 200: S9-15.
3. O'Ryan M, Peña A, Vergara R, Díaz J, Mamani N, Cortés H, et al. Prospective characterization of norovirus compared with rotavirus acute diarrhea episodes in Chilean children. Pediatr Infect Dis J 2010; 29: 855-9.
4. O'Ryan M, Pérez-Schael I, Mamani N, Peña A, Salinas B, González G, et al. Rotavirusassociated medical visits and hospitalizations in South America: a prospective study at three large sentinel hospitals. Pediatr Infect Dis J 2001; 20: 685-93.
5. Kirkwood C. Genetic and antigenic diversity of human rotaviruses: potential impact on vaccination programs. J Infect Dis 2010; 202: S43-48.
6. Linhares A, Stupka J, Ciapponi A, Bardach A, Glujovsky D, Aruj P, et al. Burden and typing of rotavirus group A in Latin America and the Caribbean: systematic review and meta-analysis. Rev Med Virol 2011; doi: 10.1002/rmv.682.
7. Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005; 15: 29-56.
8. O'Ryan M, Hermosilla G, Osorio G. Rotavirus vaccines for the developing world. Curr Opin Infect Dis 2009; 22: 483-9.
9. Hull J, Tell E, Kerin T, Freeman M, Esona M, Gentsch J, et al. United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J 2011; 30: S42-S47.
10. Madhi S, Cunliffe N, Stelle D, Witte D, Kirsten M, Louw C, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010; 362: 289-98.
11. Glass R, Parashar U, Bresee J, Turcios R, Fischer T, Widdowson M, et al. Rotavirus vaccines: current prospects and future challenges. Lancet 2006;368: 323-32.
12. Ruiz-Palacios G, Pérez-Schael I, Velásquez R, Abate H, Breuer T, Costa S, et al. Safety and effi cacy of an attenuated vaccine against rotavirus severe gastroenteritis. N Engl J Med 2006;354: 11-22.
13. Vesikari T, Matson D, Denehi P, Van Damme P, Santosham M, Rodríguez Z. Safety and effi cacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354: 23-33.
14. Gurgel R Q, Correia J B, Cuevas L E. Effect of rotavirus vaccination on circulating virus strains. Lancet 2008; 371: 301-2
15. Nakagomi T, Cuevas L E, Gurgel R, Elrokhi S H, Belkhiv Y A, Abugalia M, et al. Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine. Arch Virol 2008; 153: 591-3
16. Sáfadi M A, Berezin E N, Munford V, Almeida F J, de Moraes J C, Pinheiro C F, et al. Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo, Brazil. Pediatr Infect Dis J 2010; 29, 1019-22.
17. Zeller M, Rahman M, Heylen E, De Coster S, De Vos S, Arijs I, et al. Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. Vaccine 2010; 28: 7507-13.
18. Kirkwood C D, Boniface K, Barnes G L, Bishop R F. Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix and RotaTeq, into the national immunization program of Australia. Pediatr Infect Dis J 2011; 30: S48-S53.
19. O'Ryan M, Mamani N, Avendaño L, Cohen J, Peña A, Villarroel J, et al. Molecular epidemiology of human rotaviruses in Santiago, Chile. Pediatr Infect Dis J 1997; 16: 305-11.
20. Vergara R, Navarrete M, Núñez E, Escobar L, Navarro S, Venegas G, et al. Impacto de gastroenteritis severa por rotavirus en niños chilenos menores de 3 años de edad. Rev Med Chile 2007; 135: 975-81.
21. O'Ryan M, Díaz J, Mamani N, Navarrete M, Vallebuono C. Impact of rotavirus infections on outpatient clinic visits in Chile. Pediatr Infect Dis J 2007; 26: 41-5.
22. Iturriza-Gomara M, Kang G, Gray J. Rotavirus genotyping: keeping up with an evolving population of human rotaviruses. J Clin Virol 2004; 31: 259-65.
23. Cook S, Glass R, LeBaron C, Ho M. Global seasonality of rotavirus infections. Bull World Health Organ 1990; 68 (2): 171-7.
24. Kane E, Turcios R, Arvay M, García S, Bresee J, Glass R. The epidemiology of rotavirus diarrhea in Latin America. Anticipating rotavirus vaccines. Rev Panam Salud Pública 2004; 16: 371-7.
25. ÓRyan M. The ever changing landscape of rotavirus serotypes. Pediatr Infect Dis J 2009; 28: S60-S62.
26. Abdel-Haq N, Amjad M, McGrath E, Chearskul P, Amer A, Salimnia H, et al. Emergence of human rotavirus genotype G9 in Metropolitan Detroit between 2007 and 2009. J Med Microbiol 2011; 60: 761-7.
27. Esteban L, Rota R, Gentsch J, Jiang B, Esona M, Glass R, et al. Molecular epidemiology of group A rotavirus in Buenos Aires, Argentina 2004-2007: Reemergence of G2P[4] and emergence of G9P[8] strains. J Med Virol 2010; 82: 1083-93.
28. Ribas M, Nagashima S, Calzado A, Acosta G, Tejero Y, Cordero Y, et al. Emergence of G9 as a predominant genotype of human rotaviruses in Cuba. J Med Virol 2011; 83: 738-44.
29. Sherchand J, Nakagomi O, Dove W, Nakagomi T, Yokoo M, Pandey B, et al. Molecular epidemiology of rotavirus diarrhea among children aged < 5 years in Nepal: Predominance of emergent G12 strains during 2 years. J Infect Dis 2009; 200: S182-7.
30. Iturriza-Gómara M, Dallman T, Bányai K, Böttiger B, Buesa J, Diedrich S, et al. Rotavirus genotypes co-circulating in Europe between 2006 and 2009 as determined by EuroRotaNet, a pan-European collaborative strain surveillance network. Epidemiol Infect 2011; 139: 895-909.